Composition
- Active ingredients
- INSULIN GLULISINE RECOMBINANT 300 UNITS/3ML (100 UNITS/ML)
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- INSULIN GLULISINE RECOMBINANT 1000 UNITS/10ML (100 UNITS/ML) · InjectableBLA021629-001 · Prescription
- INSULIN GLULISINE RECOMBINANT 300 UNITS/3ML (100 UNITS/ML) · InjectableThis page
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application BLA021629.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Apidra
- Active substance
- insulin glulisine recombinant
- Route
- Intravenous, Subcutaneous
- Dosage form
- Injectable
- Applicant
- Sanofi Aventis US
- Status
- Discontinued
- FDA approval
- 16 Apr 2004
- Application
- BLA021629-002